BioHourly.com is the subsidiary of 'Bio Hourly Limited' (UK Company number 10484196). We are
international investment group dedicated exclusively to the life
sciences and healthcare sectors. Since its founding in 2010, 'Bio Hourly Limited' has formed six venture capital funds, which total
over $10 million and have invested in more than 136 biotech
companies. Our specialist team of over 20 professionals has a
broad range of skills, including scientific and medical
expertise as well as investment, banking and legal knowledge.
Our executive and advisory network's broad scientific and
medical experience allow us to identify the most promising
financial opportunities that exist in biotech industry.
Our management team is comprised of a deliberately small, but
highly qualified and experienced core group of professionals who
provide an outstanding blend of scientific and investment
expertise, and a proven track record of delivering superb
results for our investors.
Walter Davis, M.D., Ph.D. founder
Walter Davis is the founder and
managing director of 'Bio Hourly Limited' Doctor Walter Davis has
full-cycle investing experience, successfully sourcing,
syndicating, managing and exiting investments. He graduated from
Mount Sinai School of Medicine and received his Ph.D. in
Biomedical Engineering from Columbia University. He received his
M.B.A. from Columbia School of Business. Dr. Perelman holds a B.S.
in Chemical Engineering and a B.S. in Biological Sciences.
Francis Newman co-founder
Francis Newman, is the co-founder and the senior partner
of 'Bio Hourly Limited' Dr. Newman has a background as a biotech
entrepreneur, biotech intellectual property rights expert
and business development executive, combined with a
scientific career. He has been actively involved in biotech
investment since the late 1990's. Dr. Newman holds an MSc in
chemical engineering, a PhD in molecular biology
biochemistry and an MBA.
Vera Schormann, Scientific advisor
Ms. Schormann has a strong background in
chemical research and analysis, and a superb track record of
successful project leadership. She received her M.Sc. in
Pharmaceutical Sciences from the University of Greenwich, and
her B.Sc. in Chemistry from the University of Guelph.
Howard Sumner, Investment expert
Howard Sumner has been the investment expert
of 'Bio Hourly Limited' since the company formation in 2010.
Howard has over 20 years of experience in private equity and
investment banking. He has in-depth experience investing in
healthcare industry throughout his career.
Mr. Howard holds a BA and a MBA from Cornell University.